Risk factors for "major" embolic events in hospitalized patients with infective endocarditis

American Heart Journal

Volumn 146, Issue 2, 2003, Pages 311-316

  Mangoni, Emanuele Durante ^a   Adinolfi, Luigi E ^a   Tripodi, Marie Francoise ^a   Andreana, Augusto ^a   Gambardella, Michele ^a   Ragone, Enrico ^a   Precone, Davide F ^a   Utili, Riccardo ^a   Ruggiero, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CHILD; ECHOCARDIOGRAPHY; EMBOLISM; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIFE EVENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0041989756     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(02)94802-7     Document Type: Article

References (45)

1. Bayer AS. Infective endocarditis. Clin Infect Dis 1993;17:313-22.
2. Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis 1996;22:276-86.
3. Millaire A, Leroy O, Gaday V, et al. Incidence and prognosis of embolic events and metastatic infections in infective endocarditis. Eur Heart J 1997;18:677-84.
4. Ting W, Silverman N, Levitsky S. Valve replacement in patients with endocarditis and cerebral septic emboli. Ann Thorac Surg 1991;51:18-22.
5. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936-48.
6. Jaffe WM, Morgan DE, Pearlman AS, et al. Infective endocarditis, 1983-1988: echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardiol 1990;15:1227-33.
7. Roder BL, Wandall DA, Espersen F, et al. Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med 1997;102:379-86.
8. Reinhartz O, Herrmann M, Redling F, et al. Timing of surgery in patients with acute infective endocarditis. J Cardiovasc Surg 1996;37:397-400.
9. Olaison L, Hogevik H, Myken P, et al. Early surgery in infective endocarditis. Q J Med 1996;89:267-78.
10. Le Cam B, Guivaech G, Boles JM, et al. Neurological complications in a group of 86 bacterial endocarditis cases. Eur Heart J 1984;5:97-100.
11. Siddiq S, Missri J, Silverman DI. Endocarditis in an urban hospital in the 1990s. Arch Intern Med 1996;156:2454-8.
12. Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Mecl 1991;114:635-40.
13. Sanfilippo AJ, Picard MH, Newell JB, et al. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991;18:1191-9.
14. Buda AJ, Zotz RJ, LeMire MS, et al. Prognostic significance of vegetations detected by two-dimensional echocardiography in infective endocarditis. Am Heart J 1986;112:1291-6.
15. Stewart JA, Silimperi D, Harris P, et al. Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation 1980;61:374-80.
16. Goldman ME, Fisher EA, Winters S, et al. Early identification of patients with native valve infectious endocarditis at risk for major complications by initial clinical presentation and baseline echocardiography. Int J Cardiol 1995;52:257-64.
17. Rohmann S, Erbel R, Gorge G, et al. Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocorditis. Eur Heart J 1992;13:446-52.
18. Mugge A, Daniel WG, Frank G, et al. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size and determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989;14:631-8.
19. Lancellotti P, Galiuto L, Albert A, et al. Relative value of clinical and transesophageal echocardiographic variables for risk stratification in patients with infective endocarditis. Clin Cardiol 1998;21:572-8.
20. De Castro S, Magni G, Beni S, et al. Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997;80:1030-4.
21. Gagliardi JP, Nettles RE, McCarty DE, et al. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. Clin Infect Dis 1998;26:1165-8.
22. Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. J Intern Med 1997;242:15-22.
23. Kupferwasser LI, Hafner G, Mohr-Kahaly S, et al: The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol 1999;33:1365-71.
24. Koie S, Iwase M, Hasegawa K, et al. Echocardiographic prediction of risk for embolism in patients with infective endocarditis. J Cardiol 1997;29(2 Suppl):117-22.
25. Schunemann S, Werner GS, Schulz R, et al. Embolic complications in bacterial endocarditis. Z Kardiol 1997;86:1017-25.
26. Heinle S, Wilderman N, Harrison JK, et al. Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Am J Cardiol 1994;74:799-801.
27. Durack DT, Lukes AS, Bright DK, et al. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med 1994;96:200-9.
28. Scott Harris P, Glenn Cobbs C. Cardiac, cerebral and vascular complications of infective endocarditis. Cardiol Clin 1996;14:437-50.
29. Tornos MP, Olona M, Permanyer-Miralda G, et al. Is the clinical spectrum and prognosis of native valve infective endocarditis in non-oddicts changing? Eur Heart J 1995;16:1686-91.
30. Schulz R, Werner GS, Fuchs JB, et al. Clinical outcome and echocardiographic findings of native and prosthetic valve endocarditis in the 1990s. Eur Heart J 1996;17:281-8.
31. Erbel R, Liu F, Ge J, et al. Identification of high-risk subgroups in infective endocarditis and the role of echocardiography. Eur Heart J 1995;16:588-602.
32. d'Udekem Y, David TE, Feindel CM, et al. Long-term results of surgery for active infective endocarditis. Eur J Cardiothorac Surg 1997;11:46-52.
33. Taha TH, Durrant SS, Mazeika PK, et al. Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis. J Intern Med 1992;231:543-6.
34. Kupferwasser LI, Yeaman MR, Shapiro SM, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999;99:2791-7.
35. Nicolau DP, Marangos MN, Nightingale CH, et al. Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 1995;39:1748-51.
36. Tischler MD, Vaitkus PT. The ability of vegetation size on echocardiography to predict clinical complications: a meta-analysis. J Am Soc Echocardiogr 1997;10:562-8.
37. Olaison L, Hogevik H, Alestig K. Fever, C-reactive pratein, and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 1997;157:885-92.
38. Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20.
39. Vigo C. Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. J Biol Chem 1985;260:3418-22.
40. Fiedel BA, Simpson RM, Gewurz H. Effects of C-reactive protein (CRP) on platelet function. Ann N Y Acad Sci 1982;389:263-73.
41. Fiedel BA. Influence of tuftsin-like synthetic peptides derived from C-reactive protein (CRP) on platelet behaviour. Immunology 1988;64:487-93.
42. Paschalis C, Pugsley W, John R, et al. Rate of cerebral embolic events in relation to antibiotic and anticoagulant therapy in patients with bacterial endocarditis. Eur Neurol 1990;30:87-9.
43. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
44. Mackiewicz A, Sperloff T, Ganapathi MK, et al. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991;146:3032-7.
45. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci 1982;389:406-18.